Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS.
Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS.
复制标题
DOI:
10.1002/nbm.3106
复制
发表时间:
2014-06
影响因子:
2.9
通讯作者:
Glunde, K.
中科院分区:
文献类型:
--
作者:
Wijnen, J. P.;Jiang, L.;Greenwood, T. R.;Cheng, M.;Doepkens, M.;Cao, M. D.;Bhujwalla, Z. M.;Krishnamachary, B.;Klomp, D. W. J.;Glunde, K.
Abnormal choline phospholipid metabolism is an emerging hallmark of cancer, which is implicated in carcinogenesis and tumor progression. The malignant metabolic phenotype is characterized by high levels of phosphocholine (PC) and relatively low levels of glycerophosphocholine (GPC) in aggressive breast cancer cells. Phosphorus Magnetic Resonance Spectroscopy (31P MRS) is able to noninvasively detect these water-soluble metabolites of choline as well as ethanolamine phospholipid metabolism. Here we have investigated the effects of stably silencing glycerophosphoester diesterase domain containing 5 (GDPD5), which is an enzyme with glycerophosphocholine phosphodiesterase activity, in MDA-MB-231 breast cancer cells and orthotopic tumor xenografts. Tumors in which GDPD5 was stably silenced with GDPD5-specific shRNA contained increased levels of GPC and phosphoethanolamine (PE) compared to control tumors.
登录
查看更多内容
影响因子:
5.7
作者:
Beloueche-Babari, M;Jackson, LE;Ronen, SM
通讯作者:
Ronen, SM
影响因子:
5.4
作者:
An, DS;Morizono, K;Chen, ISY
通讯作者:
Chen, ISY
影响因子:
11.2
作者:
Beloueche-Babari, M;Jackson, LE;Ronen, SM
通讯作者:
Ronen, SM
影响因子:
2.9
作者:
Klomp, Dennis W. J.;van de Bank, Bart L.;Luijten, Peter R.
通讯作者:
Luijten, Peter R.
影响因子:
3.7
作者:
Gallego-Ortega D;Ramirez de Molina A;Ramos MA;Valdes-Mora F;Barderas MG;Sarmentero-Estrada J;Lacal JC
通讯作者:
Lacal JC